Assembly Biosciences, Inc. revenue for the last year amounted to 6.49 M EUR, the most of which — 6.49 M EUR — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 5.50 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Assembly Biosciences, Inc. 6.49 M EUR, and the year before that — 5.50 M EUR.